The Effects of Percutaneous renal sympathetic denervation on cardiac function and exercise tolerance

Mehmet Mete Altintas

About 100 million people worldwide suffer from chronic heart failure (CHF), which has a 50% five-year survival rate despite the fact that pharmacological therapy can relieve symptoms. Sympathetic hyperactivity, a significant contributor to the onset and progression of heart failure (HF), is associated with both the severity and prognosis of HF.